The top vaccine and biologics drug official in the U.S. Food and Drug Administration will step down in April. The agency made multiple decisions in recent months that raised concerns within the

The polarizing fixture of Southern California politics has not filed to run again, with less than an hour to go before the deadline. Two people who were granted anonymity to discuss private